AbbVie faces yet another 'white-coat' lawsuit claiming it used kickbacks to help promote Humira

Tuesday in Delaware, when an investor filed a lawsuit against AbbVie claiming that a "white-coat" kickback scheme had exposed the firm to liability, the story had a familiar ring.

Less than two years ago, AbbVie paid $24 million to settle a fraud lawsuit from the California Department of Insurance. Last September, an Illinois judge ruled for investors, allowing that suit to advance as a class action.